Top Buy
| Security ▼ | Buy | Sell | Buy (1M) | Sell (1M) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Novocure Ltd | 1 | 1 | 0 | 0 | €21.34 | - | - |
| Novavax Inc. | 6 | 3 | 4 | 2 | €14.28 | €17.59 | 23.159% |
| Neurocrine Bioscience | 29 | 0 | 6 | 0 | €128.55 | €140.60 | 9.377% |
| Nektar Therapeutics | 3 | 1 | 0 | 0 | €1.52 | €3.70 | 143.902% |
| Natural Alternat. | 18 | 1 | 1 | 0 | €5.90 | - | - |
| Myriad Genetics | 5 | 2 | 1 | 0 | €21.40 | €25.14 | 17.495% |
| Motus GI Holdings Inc. | 2 | 0 | 0 | 0 | €0.43 | €2.33 | 443.991% |
| Molina Healthcare | 12 | 1 | 1 | 0 | €306.10 | €366.73 | 19.806% |
| Merit Medical Systems | 17 | 0 | 4 | 0 | €74.50 | €86.90 | 16.640% |
| Merck & Co. Inc. | 28 | 1 | 1 | 0 | €119.40 | €124.93 | 4.631% |
| Medpace Holdings Inc | 9 | 0 | 0 | 0 | €360.20 | €421.61 | 17.047% |
| Masimo Corp. | 7 | 1 | 1 | 0 | €117.05 | €147.62 | 26.114% |
| MannKind Corp. | 8 | 0 | 1 | 0 | €4.41 | €6.03 | 36.647% |
| MacroGenics Inc. | 13 | 0 | 5 | 0 | €4.20 | €12.42 | 195.545% |
| Lexicon Pharmaceuticals Inc. | 2 | 0 | 1 | 0 | €1.50 | €5.34 | 256.208% |
| Lemaitre Vascular Inc | 2 | 0 | 1 | 0 | €73.00 | €69.00 | -5.479% |
| Lantheus Holdings Inc | 2 | 0 | 0 | 0 | €72.12 | €80.00 | 10.926% |
| Laboratory Corp. Of America (labcorp) | 11 | 0 | 2 | 0 | €197.00 | €237.94 | 20.782% |
| Kura Oncology Inc | 1 | 0 | 0 | 0 | €19.63 | €20.00 | 1.885% |
| Krystal Biotech | 17 | 0 | 1 | 0 | €150.05 | €179.60 | 19.690% |
| Kala Pharmaceuticals Inc. | 5 | 0 | 1 | 0 | €5.92 | €19.50 | 229.367% |
| Iovance Biotherapeutics Inc. | 21 | 3 | 2 | 0 | €9.22 | €25.20 | 173.290% |
| Intuitive Surgical Inc | 34 | 0 | 0 | 0 | €373.25 | €385.48 | 3.276% |
| Intra-Cellular Therapies Inc. | 25 | 0 | 2 | 0 | €60.50 | €79.55 | 31.495% |
| Intellia Therapeutics Inc | 13 | 1 | 1 | 1 | €22.91 | €60.55 | 164.313% |